The latest report by Custom Market Insights reveals significant growth in the global Medical Radioisotopes Market, projected to increase from approximately USD 745 million in 2024 to around USD 1.382 billion by 2034, at a CAGR of 6.34%. The demand is driven by the rising incidence of chronic diseases and the growing applications of radioisotopes in diagnostics and therapeutics, particularly for nuclear medicine procedures. Technetium-99m (Tc-99m) remains the most widely used isotope, constituting over 80% of nuclear medicine applications globally. The market is supported by advances in nuclear medicine infrastructure, government investments, and new production technologies, particularly cyclotron-based methods, reducing reliance on aging nuclear reactors. North America is currently leading the market, followed by Europe and Asia-Pacific, with the latter expected to experience the fastest growth due to increased healthcare expenditure and nuclear medicine adoption.
Thu, 20 Mar 2025 08:32:08 GMT | GlobeNewswire